What Is Axe Compute (AGPU) and Why Its Aethir Reserve Lost $9 Million in a Quarter

Axe Compute (AGPU) marked its Aethir ATH treasury down to $11,144,775 on 30 June 2026, and its 10-Q filed 14 August 2026 puts the quarter's fall at $9,088,470. The company traded as Predictive Oncology until 11 December 2025, and it sells GPU compute under long-term service agreements.

That $9 million is three different things at once. The filing books $6,724,378 of it as an unrealized loss and $1,329,854 as a realized loss, and it books another $1,111,134 as ATH the company spent buying compute. Axe Compute still held 2,655,414,499 ATH on 30 June 2026.

What Is Axe Compute and What Does the Company Sell?

The 10-Q describes a company that buys large-scale GPU capacity from hardware manufacturers and infrastructure suppliers and deploys it for enterprise customers. Two models run side by side. The first designs and builds dedicated infrastructure that the company finances, owns and operates, with take-or-pay terms and multi-year service agreements. The second resells capacity that already runs on third-party networks, which the filing says can reach a customer in 24 to 48 hours.

One of those third-party networks is Aethir. If you want the mechanics of how decentralized AI compute networks work, that's the layer underneath the ATH line on the balance sheet.

The risk factors carry an admission the marketing does not. Axe Compute ran an asset-light model that owned no hardware at all. It has expanded into purchasing, owning and operating GPU machines, and the filing calls that shift substantially more capital-intensive than the model it replaced. That change is what the $17.1 million of property and equipment spending in the first half of 2026 pays for.

The revenue behind it is contracted. At 30 June 2026 the company reported $60,754,672 of remaining performance obligations. In July 2026 it disclosed three new customer contracts with a total contract value above $2.8 billion across the United States and Europe.

How Did Predictive Oncology Become Axe Compute (AGPU)?

The Predictive Oncology name change ran through Delaware on 9 December 2025 and took effect two days later. Nasdaq moved the ticker to AGPU on or about 12 December 2025. Before that came the arithmetic nobody enjoys. Stockholders approved a one-for-fifteen reverse stock split on 19 September 2025, the company completed it on 29 September, and trading reflected it from 30 September 2025.

The treasury strategy started the same week the split did, on 29 September 2025.

The oncology business left in pieces. Skyline Medical went to DeRoyal Industries in March 2025, and Helomics went to DataMeds AI on 11 September 2026. The 8-K filed on 17 September 2026 says the sale of Helomics "completes the Company's strategic transition to a pure-play neocloud GPU-as-a-Service company". Helomics was the last operating business left from the Predictive Oncology years.

Shareholders paid for the transition in the usual currency. Shares outstanding went from 4,083,173 at 31 December 2025 to 5,539,267 at 31 March, then to 11,384,940 at 30 June and 11,591,124 by 13 August 2026. That is 183.9 percent more stock in seven and a half months, all of it after the reverse split.

What Sits Inside the Aethir ATH Treasury?

ATH is the token of the Aethir network, which the filing describes as a decentralized infrastructure network developed by DCI Foundation, a Panama foundation company. The reserve exists so the company can buy compute on that network and resell it. The filing is blunt that holding the token means carrying its price.

The numbers are filed, and they are specific. Axe Compute held 2,837,163,868 ATH at 31 December 2025 against a cost basis of $101,258,178, and 2,655,414,499 ATH at 30 June 2026 against a cost basis of $94,739,253. The fair value on that second date was $11,144,775, which is 11.8 cents on every dollar of cost.

A side letter with DCI took effect on 7 October 2025. It grants the company bonus tokens equal to 20 percent of anything it buys on the open market, delivered within 30 days. The company made no open-market purchases in the first half of 2026, so it received no bonus tokens.

Then there is the ATH the company does not yet control. Locked tokens sit behind a vesting contract on Ethereum. The filing carries them as a $10.3 million receivable, built from a $93.4 million host receivable netted against an $83.1 million embedded derivative liability. Vesting runs from under a month to roughly three years, with 1.6 billion tokens due within twelve months of 30 June 2026 and another 1.6 billion after that.

The $9 Million Quarter, Line by Line

Start at $20,233,245, the fair value of the ATH position on 31 March 2026. The company bought nothing during the June quarter. It spent $1,111,134 of ATH on operations and earned $76,896 of interest from lending tokens out. Then it booked $1,329,854 of realized losses and $6,724,378 of unrealized losses. The position finished the quarter at $11,144,775.

Call the whole $9,088,470 a markdown and you overstate the market's part by a quarter. Roughly three-quarters of the fall is the price of the token moving against a position the company already held, and the remainder is tokens spent and tokens sold.

Stretch the window to six months and the fall is $13,294,559, from $24,439,334 at 31 December 2025. The profit and loss line reads larger still at $17,421,620, because it folds in a $5.2 million move in the embedded derivative attached to the locked tokens. Three defensible numbers describe the same treasury, and the one you quote depends on the question you asked.

What Do the Filed H1 2026 Numbers Show?

Revenue for the six months to 30 June 2026 was $3,250,303 against $112,992 a year earlier. That comparison flatters the business, because the prior-year figure came from drug discovery. Cost of revenues was $3,016,195, which leaves $234,108 of gross profit on the half, a margin of 7.2 percent.

The net loss was $24,914,825 for the half and $17,205,882 in the June quarter alone.

Cash tells a friendlier story. The company finished the half with $21,905,767, up $11.1 million from 31 December 2025, and operations threw off $17.3 million of that. The engine is a $60.6 million rise in contract liabilities, which means customers prepaid for compute. The company prepaid $34.1 million for compute of its own in the same period.

Where Does the AGPU Perpetual Futures Contract Trade?

Axe Compute stock trades on Nasdaq under the AGPU ticker, and Phemex lists a perpetual on the same name. The AGPU perpetual futures contract went live at 10:00 UTC on 20 September 2026, alongside six other US stock perpetuals. The API gives maximum leverage of 10x and a funding interval of 28,800 seconds, so funding settles every eight hours. Each contract tracks one share.

The perpetual is a derivative on the share price and it delivers no equity, which is the line that separates it from tokenized stocks and their share-backed claims.

The contract holds exactly one daily bar so far. It opened at 12.51 and closed at 12.39, an open-to-close move of -0.96 percent that made it the weakest of the seven new listings. The high was 12.75 and the low was 12.29. Turnover on that bar was $7,965 out of $126,967 across all seven, so the price you see came from a very small amount of trading. If the mechanics of TradFi futures contracts are new to you, start there before sizing anything.

Against 11,591,124 shares outstanding at 13 August 2026, that 12.39 mark implies roughly $143.6 million. The ATH reserve at $11,144,775 is under a tenth of that, the opposite of the ratio a treasury company usually advertises.

Why Did AGPU Print a Bar While the US Market Was Shut?

The 20 September 2026 bar is a Sunday bar. CME closes from 21:00 UTC on Friday to 22:00 UTC on Sunday, and the US cash equity market closes all weekend. That 12.39 is a weekend mark and not a session of the underlying share. Treat it as a quote, never as a close the stock produced. We covered the same effect when a stock perpetual moved with its cash market shut.

The bar is also 14 hours long, because the contract listed at 10:00 UTC. Pricing a stock perpetual before the underlying reopens is its own discipline, and the pre-market perpetual futures guide walks through what the mark is doing in those hours.

What Are the Specific Risks in Axe Compute Stock?

Two customers produced 76 percent of revenue in the six months to 30 June 2026, at 49 percent and 27 percent. Losing either one rewrites the model, and the filing names no replacement.

Dilution is the second. The share count rose 183.9 percent between 31 December 2025 and 13 August 2026. The SEC declared a shelf registration effective on 20 July 2026 that permits up to $1 billion of securities. An ATM facility and a SEPA facility run alongside it.

The third is the token itself. Another 1.6 billion ATH vests within twelve months of 30 June 2026, into a reserve already carried at 11.8 percent of cost. Any further weakness lands straight in the income statement under ASC 350-60.

The fourth is the contract's own liquidity. A position that traded $7,965 in its first 14 hours can gap on an order that wouldn't move a mature market. Your stop matters more than your thesis here.

Method: the figures above come from the 10-Q for the period ended 30 June 2026 and from two 8-Ks filed on 17 September 2026 and 11 December 2025. Contract terms and the 20 September bar come from the Phemex product and kline API. The company's investor subdomain didn't resolve when we tried it, so nothing here rests on it.

Frequently Asked Questions

What did Axe Compute get for Helomics?

636,328 DataMeds AI shares, equal to 19.99 percent of that company before closing, plus a convertible note of $1,363,672 at a $1.00 conversion price. Both are locked up for 12 months from closing.

Did Axe Compute lend out its ATH?

Yes. It transferred 2.4 billion ATH through the Aethir portal for 31 calendar days at 6 percent simple annual interest, and the principal and interest came back in full. No tokens were out on loan at 30 June 2026.

How much cash did the company hold before the June quarter?

$6,925,244 at 31 March 2026, which makes the $21,905,767 three months later a financing and prepayment story more than an operating one.

When does the contracted revenue land?

The filing schedules $29,301,246 of the $60.8 million for the last six months of 2026, then $7,053,109 in 2027, $1,906,741 in 2028 and $22,493,576 in 2029.

Bottom Line

The shorthand on AGPU says a GPU company blew up its crypto treasury. The filing says something more awkward and more useful. It names the tokens, prices them at 11.8 cents on the dollar of cost, and then shows a contracting business underneath that took $60.6 million of customer prepayments in six months and signed more than $2.8 billion of new work in July. The treasury is the loud part and the margin is the quiet one, and at 7.2 percent gross on the half, the margin is the number that decides what the rest of it is doing.

Disclaimer: This article is for informational purposes only and is not financial advice. Cryptocurrency trading involves substantial risk. Always do your own research before making investment decisions.